Navigation Links
Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
Date:10/28/2008

ORANGE COUNTY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), announced today that it has signed new sole source agreements with Adventist Health to provide a broad range of core laboratory systems and supplies valued at approximately $36 million over six years. Adventist Health is a not-for-profit, faith-based health care system with facilities in California, Hawaii, Oregon, and Washington.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Under the terms of the new six-year agreements, Adventist Health hospital laboratories will continue to purchase hematology products from Beckman Coulter, and will add the company's complete line of automated chemistry and immunoassay analyzers and reagents to their owned, leased and managed facilities. An expanding group of more than 38 acute-care affiliate organizations will also be able to purchase systems under the contract.

In making the decision, Adventist Health cited Beckman Coulter's ability to deliver cutting-edge technologies that can help their physicians deliver prompt and effective patient care. Lowell Church, assistant vice president, said, "We are constantly striving to enhance quality care, increase patient safety and improve outcomes, in addition to controlling costs. Beckman Coulter has the same vision and goals and we look forward to collaborating with them."

David Bespalko, corporate vice president of sales in North America for Beckman Coulter, said about the contract, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our innovative systems sim
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. Beckman Coulter Investor Events Second Half of 2008
4. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
5. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
6. Beckman Coulter Announces Second Quarter 2008 Results
7. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
8. Upcoming Beckman Coulter Investor Events Second Half of 2008
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Beckman Coulter Announces First Quarter 2008 Results
11. Beckman Coulter Acquires Rights to Hepatitis C Virus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... As global temperatures and energy costs continue ...o a sustainable future. An attractive replacemen...ished online in Genome Research ( www.genome.org... of bioethanol-producing microorganisms, uncoverin...g new technologies needed to implement production ...
(Date:11/6/2009)...io, Nov. 6 Helix BioPhar...day announced that John Docherty, president and ch...rhan Ford,s 6th annual Investor Summit on November...ork City. Mr. Docherty will provide an overview o...ms L-DOS47 and Topical Interferon Alpha-2b. The s...
(Date:11/6/2009)... 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc...pany") today announced updated results from a Phas...with sarcomas metastatic to the lung in a poster p...ncology Society Meeting held in Miami Beach, Flori...ion, entitled "A Phase II Study of Intravenous REO...
(Date:11/5/2009)...olo., Nov. 5 The endangered black-...stern U.S. This rare carnivore feeds on prairie d...ague and often entire population die-offs in towns...) has implemented a ferret breeding program and ha...ir formerly native habitat. Unfortunately, plague...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
.... (Pink,Sheets: BMGP) has been rated Speculative B...esearch Analyst, Lisa Springer, CFA., The full re...., Anyone interested in receiving alerts regardin...members@beaconequity.com with "BMGP" in,the subje...magnetics Diagnostics Corp.,(BMGP) is a biotechnol...
...he nanoworld, researchers at the National Institut...rsity of Maryland-College Park have discovered tha...in bulk form behave as ductile as gold at the nano...re nanomachines. , NIST scientists Pradeep Namboo...ted* the latest incongruity between the macro and ...
...Nasdaq: DCGN ) today announced its consolidated f...cember 31, 2007. A conference call to discuss the,...bcast live tomorrow,Thursday, March 13, at 8:00am ...e year ended December 31, 2007 was $95.5 million,c...asic and diluted net,loss per share was $1.57 for ...
Other Biology Technology:BioMagnetics Diagnostics Corp. Rated 'Speculative Buy,' Target Price $1.42 by Beacon Equity Research 2Nanomaterials show unexpected strength under stress 2deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9
(Date:11/6/2009)...burn Hills, MI-based Law Enforcement Intelligent D...ystem and patent-pending Biometric Access Control ... and Human Services, National Institutes of Health...ill support the NIH,s entire police force that is ...search agency. The project is expected to be comp...
(Date:11/5/2009)... a training grant in the amount of $2,756,719 by t...ve Graduation Education and Research Training (IGE...warded to Kent State. The grant, which is funded u... 2009, runs through 2014. , The grant funds an I...esource sensing (EARS). The purpose of the program...
(Date:11/4/2009)...hood obesity in the United States is reaching epid...ertising on daytime and prime time television devo...s about the role television plays in obesity, a st... of Nutrition Education and Behavior examines how...ge contributor to the problem. , Researchers at ...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Researchers Spot Genes Linked to Testicular Cancer 47451 1Researchers Spot Genes Linked to Testicular Cancer 47451 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 1FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 3FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 4FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 5FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 6
...ark December 13, 2007 The Juvenile Diabetes Rese...nder of type 1 diabetes research, awarded Professo...nhagens Department of Medical Biochemistry and Gen... cell regeneration and expansion during pregnancy ...or the treatment of type 1 diabetes. , The projec...
...University of Pennsylvania researchers have uncove... HSV-1, uses cooperating proteins found on its out...t them. Further, the studys authors say, they hav...se protein interactions using biomolecular complem...dings of the National Academy of Sciences, provide...
...ectly connect silicon circuits with brains are und...re nearing commercial application in many areas, a...ologist Theodore W. Berger of the University of So...ee which compiled the "International Assessment of...aces," published in October by the World Technolog...
Other Biology News:JDRF awards University of Copenhagen professor with grant to conduct innovative diabetes research 2Penn researchers shine the light of venus to learn how the herpes virus invades cells 2Brain-computer link systems on the brink of breakthrough, study finds 2
Cell biology services from Novascreen-a Caliper Life Sciences Company
Conditioned Media Production Services from ARVYS Proteins, Inc.
... hunting and analyzing the rare transcripts using ... projects, microarrays, functional screenings etc....r the normalization of long cDNA. The Evrogen TRIM...ization of cDNA enriched with full-length sequence...
...the field of Enzyme-Linked Immunosorbent Assays (E...on the market. Freedom EVO easily manages up to 40...washing steps. The integration of different modu...asher), all controlled by the dynamic scheduling s...
Biology Products: